The charge: violating the U.S. Foreign Corrupt Practices Act. Pfizer's drug sales reps paid bribes to get Pfizer drugs used by doctors in countries like China, Russia and Bulgaria.
Pfizer seems to be weathering the loss of its patent for Lipitor just fine. The drug company says its second quarter profit jumped 25 percent. That's despite lower revenue, and competition from generics for its cholesterol-fighting blockbuster.